Jun 28, 2025, 14:47

DoD FY25 Rare Cancers Resource and Community Development Award (RCDA)

Supports the creation of shared research resources and clinical/preclinical data platforms for rare cancers (≤6 cases per 100,000/year in the U.S.), with emphasis on patient-advocate partnership, community building, data dissemination, and long-term sustainability.

Eligibility Criteria:

Applicant Organizations: Extramural or intramural U.S. or foreign academic institutions, biotechnology companies, foundations, DOD laboratories, and other public or private entities (for-profit and non-profit).
Principal Investigator: Independent investigator at or above assistant-professor level (or equivalent) by award activation.
Research Sites: Non-profit academic, medical, or research centers (U.S. or abroad). For-profit institutions may collaborate but cannot receive funds.
Patient Advocate Partnership: Must include at least two rare-cancer patient advocates as integral team members from project conception through execution.
Resource Focus: Development of data/reagent/model repositories, centralized databanks, patient registries, “Omics” databases, or longitudinal study platforms applicable across multiple rare-cancer subtypes.
No Clinical Trials: Observational clinical research permitted; interventional trials are excluded.

Funding Details:

Amount: Up to 1.12 million USD total cost (direct + indirect)
Term: Maximum period of performance 4 years; funds expire September 30, 2031
Allowable Costs: Personnel, supplies, equipment, limited travel, data-sharing infrastructure; indirect costs per negotiated rates; no tuition or clinical-trial expenses .

Deadlines:

Pre-Application (LOI): July 1, 2025, by 5 p.m. ET
Invitation to Full Application: August 8, 2025
Full Application: October 6, 2025, by 11:59 p.m. ET
Verification Period Ends: October 9, 2025, by 5 p.m. ET

Where to Go for Further Information:

View the program announcement.
Application details.

cancer CDMRP community building Data Sharing DoD-funding eBRAP grant opportunity OncoDaily Oncology Patient Advocacy Rare Cancers repository resource-development sustainability translational research

Yüksel Ürün: Science Is Better When It’s Shared

Oliver Bogler: Grant Tips

Marty Makary: FDA Has Published More than 200 Complete Response Letters

In Memory of Zelig Eshhar: The Man Who Taught T Cells to Fight Cancer

King Albert II’s Brave Battle: A Decade of Fighting Skin Cancer